How to Set Up a TB Lab Dashboard for Real-Time KPI Monitoring
A tuberculosis laboratory dashboard turns routine testing data into an operational view that staff can use during the working day. Instead of waiting for a monthly report, managers can see whether specimens are arriving correctly, whether testing is progressing within target times, and where a delay is developing.
For an Australian TB service, the dashboard may need to connect information from a metropolitan reference laboratory, regional hospitals, community collection points and interstate referral pathways. A specimen collected in Darwin or Broome can involve different transport conditions and longer travel times than one collected in inner-city Melbourne or Sydney. Those realities need to be visible in the performance data.
The dashboard should support the laboratory’s quality management system rather than create a separate reporting burden. Its indicators should align with documented procedures, staff responsibilities, equipment controls, internal quality control, assessment activities and continual improvement. The GLI Quality Tool provides practical quality management guidance that can help laboratories connect dashboard measures with a structured improvement programme.
A useful system also distinguishes between an early warning and a confirmed failure. A rising rejection rate may point to a collection problem, while a slower turnaround time may reflect a courier disruption, instrument maintenance, staff leave or a sudden increase in presumptive TB referrals. The purpose is to make these signals visible early enough for a controlled response.
Define The Decisions Behind Each Indicator
Begin with decisions, rather than software. Ask what the laboratory needs to know each day, who will act on the information, and what threshold should trigger investigation. A scientist may need to see pending molecular tests, while a quality manager may focus on rejected specimens, amended reports and overdue corrective actions.
A compact KPI set might include specimen acceptance rate, rejection rate by reason, time from collection to receipt, time from receipt to test registration, turnaround time for molecular testing, culture contamination rate, proportion of reports issued within target, equipment downtime and unresolved nonconformities. Each measure should have a clear numerator, denominator, data source, owner and review frequency.
Use operational definitions that remain stable over time. “Turnaround time” could mean receipt to verified result, while a clinical service may need collection to verified result. Both are valid, but combining them would make comparisons unreliable. Record exclusions for public holidays, referral testing, instrument outages or specimens requiring additional work.
Build A Reliable Data Flow
Map the route from specimen collection to final report before choosing a visual design. Identify where each data element is entered: laboratory information system, electronic request form, courier log, instrument middleware, quality register or incident database. In Australia, state and territory services may use different platforms, so a dashboard may need a controlled data extract rather than a direct, unified connection.
Assign responsibility for data quality at every hand-off. A missing collection time can distort transport performance, and an incorrect specimen category can make rejection statistics appear better or worse than they are. Use required fields, standard dropdown values and validation rules wherever possible, while retaining a free-text field for unusual events.
Specimen acceptance data deserves particular attention because it often exposes preventable upstream problems. The specimen acceptance criteria guide can support consistent definitions for unsuitable containers, missing identifiers, inadequate volume, leakage, delayed transport and incorrect storage. Coding the reason for rejection allows the laboratory to address recurring causes with collectors and referring services.
Select KPIs That Explain Performance
A dashboard should combine leading and lagging indicators. The number of overdue tests is a lagging signal because the delay has already occurred. The number of specimens approaching the reporting limit is a leading signal, giving staff an opportunity to intervene before the target is missed.
Show trends as well as current values. A rejection rate of 4% may look acceptable in isolation, but a steady rise from 1.5% over eight weeks warrants attention. Break down results by collection site, referring facility, specimen type, transport route and rejection reason, while taking care not to expose identifiable patient information.
TB testing also requires clinically meaningful stratification. Separate smear microscopy, nucleic acid amplification, culture, identification and drug susceptibility testing where their workflows and target times differ. A single average turnaround time can conceal a serious delay in culture confirmation or susceptibility reporting.
Design Views For Different Users
Create a small number of role-based views rather than putting every metric on one screen. A bench-level view might show work awaiting registration, tests in progress, instrument status and specimens nearing their target time. A laboratory manager’s view can include workload, staffing capacity, trends, open incidents and corrective action ageing.
Use simple visual conventions. Green, amber and red status bands should be tied to documented thresholds, not personal preference. Include the actual value, target, time period and sample size beside each chart. A red result with a denominator of three means something different from a red result based on 900 specimens.
The dashboard should work on an ordinary desktop in a laboratory office and remain readable during handover. Large tiles are useful for urgent exceptions, while trend charts and filters support investigation. Avoid unnecessary animation and dense displays that encourage staff to watch the screen without taking action.
Govern Access, Privacy And Change
A TB dashboard handles sensitive health information, even when it displays aggregated measures. Apply role-based access, secure authentication, audit logs and retention rules consistent with the laboratory’s information governance arrangements. Patient identifiers should be hidden from routine management views, with access to line-level records limited to staff who need it for investigation.
Document who owns each KPI and who may change its definition. A revised reporting target can create an artificial improvement if historical data are not recalculated or clearly annotated. Keep version-controlled records of formulas, source fields, exclusions and threshold changes.
Australian laboratories should also consider local accreditation and quality expectations. A dashboard does not replace evidence required for NATA assessment or relevant RCPA and state or territory procedures; it helps organise that evidence and identify gaps earlier. Changes to the dashboard should pass through the same document control and approval process as other quality system changes.
Turn Alerts Into Improvement Actions
Real-time monitoring has value only when an alert leads to a defined response. For example, three consecutive rejected specimens from one collection centre might trigger a review of collection instructions, packaging, transport timing and staff competency. A sudden fall in culture throughput might prompt checks of incubator conditions, media availability, instrument status and roster coverage.
Set an escalation pathway for each critical indicator. The bench scientist may resolve a missing request detail, the section lead may manage an instrument interruption, and the quality manager may open a corrective action for a recurring system failure. Include the action, owner, due date and closure evidence in the same workflow or in a linked quality register.
Review dashboard performance at a regular quality meeting, using run charts and documented decisions rather than screenshots alone. Consider whether the indicator changed behaviour, exposed a genuine risk or encouraged staff to optimise the number instead of the underlying process. Retire measures that no longer support patient care or laboratory control.
Practical Checks Before Go-Live
Use these checks to test whether the dashboard is ready for routine use:
- Confirm every KPI has a written definition, data owner, target and escalation threshold.
- Reconcile dashboard totals with the laboratory information system for several completed reporting periods.
- Test missing values, duplicate records, amended reports, cancelled tests and instrument downtime.
- Compare performance across metropolitan, regional and remote referral pathways.
- Remove patient identifiers from management screens and verify role-based access.
- Run a short pilot with bench staff, supervisors, couriers and quality personnel.
- Record user feedback, correct calculation errors and approve the final version through document control.
Once live, schedule a brief daily exception review and a deeper weekly trend review. In services supporting remote communities, include transport conditions and courier frequency in the interpretation. A delay affecting a regional pathway may require a different remedy from a delay caused by local registration backlog.
The dashboard should become part of normal laboratory practice: reviewed during handover, discussed during quality meetings and linked to corrective and preventive action. Start with a limited set of trustworthy indicators, verify them against source records, and expand only when the team can act on the additional information. A well-governed dashboard gives Australian TB laboratories a clearer view of risk, workload and service reliability while strengthening the wider quality management system.